Top Stories

Colorado’s Life Sciences Ecosystem Raised $1.47 Billion in 2023

For Immediate Release: December 21, 2023 Fundraising Success Demonstrates Colorado’s Resilience Duri...

Learn More

Join CBSA for Diversity, Equity, and Inclusion Workshops in June + July

CBSA is committed to advancing Diversity, Equity, and Inclusion (DEI) in Colorado's life sciences co...

Learn More

Colorado BioScience Association to Recognize Outstanding Companies and Leaders at Annual Awards Celebration

Aktiv Pharma Group, BioIntelliSense, and Umoja Biopharma Selected as Finalists for Company of the Ye...

Learn More

Colorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors

Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Teru...

Learn More

Colorado’s Life Sciences Community Raises $1.2 Billion in First Two Quarters of 2024

Public and Private Investments and Federal Grants Contribute to Total Colorado’s life sciences commu...

Learn More

Weekly Policy Blog: FTC Blasts PBMs in New Report

7/16/24  CBSA has consistently advocated for PBM reform at the state and federal level. Followi...

Learn More

Get weekly updates from Colorado’s leading source
for life sciences news and information.

Join Mailing List
Media Resources

Colorado’s Life Sciences Community Raises $1.2 Billion in First Two Quarters of 2024

Public and Private Investments and Federal Grants Contribute to Total Colorado’s life sciences community raised $1.2 billion in the first two quarters of 2024. Public and private capital, as well as f...

Learn More

Weekly Policy Blog: FTC Blasts PBMs in New Report

7/16/24  CBSA has consistently advocated for PBM reform at the state and federal level. Following the release of an interim report from the Federal Trade Commission (FTC) blasting the business pr...

Learn More

Weekly Policy Blog: PDAB Moves Two More Drugs to Upper Payment Limit Rulemaking Process

On July 3, the Colorado Prescription Drug Affordability Board (PDAB or Board) voted to initiate the upper payment limit (UPL) rulemaking process for two more drugs, Stelara and Cosentyx, after deeming...

Learn More

Fitzsimons Innovation Community Master Plan: Holistic. People-Focused. Community-Forward.

A conversation with Fitzsimons Innovation Community partner and Master Plan creator, Tryba Architects. By: Fitzsimons Innovation Community In creating the plan for a 184-acre innovation campus, Fitzsi...

Learn More

Weekly Policy Blog: Urge Congress to Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program  

CBSA and BIO urge you to reach out to Senator Hickenlooper to encourage his support of S.4583, a bill that would reauthorize the rare pediatric disease priority review voucher (PPRV) program before it...

Learn More

Weekly Policy Blog: CBSA Policy News Roundup—BIO International Convention and Prescription Drug Affordability Events 

This past week, the CBSA team represented our community and shared our expertise on prescription drug affordability at the BIO International Convention and through a series of virtual events:  El...

Learn More

Weekly Policy Blog: EPA, FDA, and USDA Release Joint Regulatory Plan for Biotechnology

CBSA and our partners at Biotechnology Innovation Organization (BIO) welcome the joint plan that the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), and the U....

Learn More

Bringing Life Sciences Innovators Home to Colorado

New eBook helps health innovators choose the right location for growth. By: Fitzsimons Innovation Community Fitzsimons Innovation Community is proud to present a new resource for life sciences compani...

Learn More

Boettcher Foundation Awards $2 Million to Colorado’s Leading Biomedical Researchers

Foundation Marks 15th Year with the 2024 Class of Boettcher Investigators DENVER, May 22, 2024 — Boettcher Foundation announces its 2024 Class of Boettcher Investigators today, eight leading Colorado...

Learn More

Weekly Policy Blog: LDT Final Rule Published 

The U.S. Food and Drug Administration (FDA) published a final rule overhauling its approach to the regulation of laboratory developed tests (LDTs) on May 6, 2024. The final rule, which is largely simi...

Learn More

CBSA Congratulates May 2024 Advanced Industries Accelerator Grant Recipients

Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Association cong...

Learn More

Weekly Policy Blog: Colorado’s 2024 Legislative Session Wraps Up  

Colorado’s 2024 legislative session, the Second Regular Session of the 74th General Assembly, concluded on May 8, the 120th day of session. During the final weeks of session, the Colorado BioScience A...

Learn More

Weekly Policy Blog: HB24-1446 Supports Professional Development for Science Teachers 

HB24-1446, a bill that supports professional development for science teachers, has passed the General Assembly and will soon be sent to Governor Polis for his signature. The bill provides funding for...

Learn More

LIGHT LABS Celebrates 10 Years of Success at Fitzsimons Innovation Community

Personal relationships are the key to success for this small lab distributor. By: Fitzsimons Innovation Community If you spend much time on the Fitzsimons Innovation Community campus, at some point yo...

Learn More

CBSA Hosts 2024 Biotech Symposium: Innovations in Regenerative Medicine

The 2024 Biotech Symposium: Innovations in Regenerative Medicine commenced on Tuesday, April 23, 2024, with opening remarks by Elyse Blazevich, CBSA President and CEO, setting the stage for an engagin...

Learn More

Weekly Policy Blog: CBSA Advocates on Federal Issues During the BIO Fly-In 

Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, represented the Colorado life sciences ecosystem and advocated for community priorities on Capitol...

Learn More

Weekly Policy Blog: Grants and Tax Credits Support Colorado’s Advanced Industries 

Two of the Capital + Growth programs supporting efforts to position Colorado as America’s epicenter for talent, investors, and life sciences-centric companies looking to start, relocate, or expand in...

Learn More

CNBC Covers the Growth of Life Sciences in Colorado

Story Emphasizes Record Investment, Top Talent, Innovative Research Collaborations, and Investments in Lab Space A glimpse inside the Center for Drug Discovery at CU Anschutz Medical Campus, led by Dr...

Learn More

A talk with April Giles, Vice President of Business Development, Fitzsimons Innovation Community

By: Fitzsimons Innovation Community The first time April Giles, Vice President of Business Development for Fitzsimons Innovation Community, spent real time on the University of Colorado School of Medi...

Learn More

Weekly Policy Blog: Amgen Lawsuit Asserts Colorado PDAB is Unconstitutional   

On March 22, Amgen, the maker of the autoimmune disease drug Enbrel, filed a lawsuit against the Colorado Prescription Drug Affordability Board (PDAB or Board) in the U.S. District Court for the Distr...

Learn More

Weekly Policy Blog: Colorado Drug Importation Program Faces Roadblocks  

Colorado is still working to become the second state, after Florida, to be authorized to import prescription drugs from Canada. The Colorado Department of Health Care Policy & Financing (HCPF) sub...

Learn More

Weekly Policy Blog: EPA Releases Final Rule for EtO Sterilization Facilities 

On March 14, the Environmental Protection Agency (EPA) released its update to the National Emission Standards for Hazardous Air Pollutants (NESHAP) final rule for ethylene oxide (EtO) commercial steri...

Learn More

Colorado BioScience Association Appoints New Board of Directors Leaders from OrganiShield and General Inception

For Immediate Release: March 19, 2024 Executives from Colorado State University, KBI Biopharma, Metro Denver Economic Development Corporation, Terumo Blood and Cell Technologies, and STAQ Pharma Join...

Learn More

Weekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub 

Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...

Learn More

Weekly Policy Blog: CBSA’s 2024 Day at the Capitol 

CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...

Learn More

Fitzsimons Innovation Community Partners with the Colorado Hub for Health Impact Campaign

Colorado’s health and life sciences industry gets a nationwide spotlight. If it has to do with health and innovation in Colorado, Fitzsimons Innovation Community is bound to be a part of it. We are es...

Learn More

New Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State    

For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...

Learn More

Weekly Policy Blog: PDAB Initiates Upper Payment Limit Rulemaking Process for the First Time 

On Friday, February 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) decided to initiate an “upper payment limit” (UPL) rulemaking process for the autoimmune disease drug Enbrel...

Learn More

Weekly Policy Blog: PDAB Deems One of Two Drugs “Unaffordable” in Recent Affordability Decisions 

On Friday, February 16, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its second and third affordability reviews, following its first decision on December 8 that the cys...

Learn More

Weekly Policy Blog: Legislative Session Update 

The first few weeks of the Colorado legislative session require intensive engagement at the Capitol and comprehensive review of proposed legislation by CBSA's Policy + Advocacy team to support a colla...

Learn More

Fitzsimons Innovation Community Presents Our Third Annual Innovation Report

A look at the accomplishments, progress, and innovation behind the buzz. At Fitzsimons Innovation Community, we know January is one of the best times to look forward, set goals, and make plans for the...

Learn More

Weekly Policy Blog: Take Action to Protect America’s Innovation Economy 

CBSA urges you to take action now to protect America’s innovation economy! The federal government is considering the use of “march-in rights” (where it could compel a patent-owner to license an invent...

Learn More

Weekly Policy Blog: Urge Congress to Fix R&D Expensing 

CBSA and our partners at BIO urge you to act now! Encourage members of Congress to pass a tax package before the end of January that includes restoration of immediate R&D expensing to protect our...

Learn More

Weekly Policy Blog: Start of the 2024 Colorado Legislative Session 

Colorado’s 2024 legislative session kicked off on Wednesday, January 10th, and will continue for 120 days until May 8th.   The Legislature: For the sixth year, Democrats have total control o...

Learn More

Weekly Policy Blog: CBSA Releases 2023 Policy + Advocacy Report 

Colorado BioScience Association (CBSA) has released its 2023 CBSA Policy + Advocacy Report, which summarizes CBSA’s engagement during the Colorado legislative session, the regulatory process to implem...

Learn More

Z Biotech Celebrates 10 years of Innovation and Partnership at Fitzsimons Innovation Community.

Back in December of 2013, Jian Zhang, Ph.D. and Founder and CEO of Z Biotech, was doing advanced research in glycobiology and just starting his company. He was a one-man show, and, in 2014, opened wit...

Learn More

Accelerating Health Innovation

Through Diversity, Equity, and Inclusion in Colorado’s Life Sciences Community Colorado BioScience Association empowers people in our life sciences community through Diversity, Equity, and Inclusion t...

Learn More

Colorado’s Life Sciences Ecosystem Raised $1.47 Billion in 2023

For Immediate Release: December 21, 2023 Fundraising Success Demonstrates Colorado’s Resilience During a Challenging Year for U.S. Life Sciences Financings DENVER – Colorado BioScience Association ann...

Learn More

Weekly Policy Blog: PDAB Deems Trikafta “Not Unaffordable” in First Affordability Decision

On Friday, December 8, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its first affordability review and unanimously voted that the selected drug, a cystic fibrosis drug...

Learn More

Changing the Game for a Thriving Local Economy

Fitzsimons Innovation Community awarded for work in economic vitality Last month, the Adams County Regional Economic Partnership (AC-REP) hosted its second annual Gamechangers Awards event. This event...

Learn More

FOR IMMEDIATE RELEASE

Colorado BioScience Association Celebrates Colorado’s Growth as a Leading Life Sciences Hub at 20th Annual Awards Celebration PharmaJet Honored as Company of the Year, Foresight Diagnostics Named Risi...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Associ...

Learn More

Weekly Policy Blog: Congratulations to CBSA’s 2023 Legislators of the Year 

On November 15, 2023, CBSA held its 20th Annual Awards Celebration presented by AGC Biologics. This annual celebration highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem, br...

Learn More

Weekly Policy Blog: Join CBSA in Asking Congress to Address the R&D Tax Now 

Join CBSA in asking Congress to support leading-edge health innovation by American life sciences companies. We are asking Congress to remove a “tax on innovation” by restoring the immediate expensing...

Learn More

U.S. EDA Grant to Grow Life Sciences Startups

Partnership Led by Innosphere Ventures Lands Major Federal Grant  The U.S. Economic Development Administration validated Colorado’s collaborative approach to building a major national and interna...

Learn More

Weekly Policy Blog: Opposition to CMS’ Proposed Medicaid Drug Rebate Program (MDRP) Rule

CBSA and other members of the Council of State Bioscience Associations (CSBA) have submitted a letter to the Centers for Medicare & Medicaid Services (CMS) expressing our deep concern with a recen...

Learn More

Weekly Policy Blog: CBSA Has Concerns About Inconsistency of Preliminary Data Review Process for Drugs Under Affordability Review by PDAB 

CBSA has serious concerns about the Colorado Prescription Drug Affordability Board’s inconsistent approach to the preliminary data review process for drugs under affordability review in the first coho...

Learn More

Weekly Policy Blog: USITC Report Released on TRIPS COVID-19 IP Waiver Expansion

In June 2022, World Trade Organization (WTO) member states agreed to waive certain WTO intellectual property protections for COVID-19 vaccines. The U.S. Trade Representative (USTR) has been considerin...

Learn More

Weekly Policy Blog: CBSA Co-Hosts Facility Tours for State Legislators and Local Leaders 

Weekly Policy Blog: CBSA Co-Hosts Facility Tours for State Legislators and Local Leaders  This month CBSA partnered with both Terumo Blood and Cell Technologies (Terumo BCT) and AGC Biologics to host...

Learn More

NEWS RELEASE

For Immediate Release: October 13, 2023 Colorado BioScience Association to Honor Life Sciences Companies at 20th Annual Awards Celebration, Presented by AGC Biologics       En...

Learn More

Weekly Policy Blog: CBSA Urges Congress to Pass the PASTEUR Act 

Earlier this month, CBSA participated in PASTEUR Advocacy Day, joining Biotechnology Innovation Organization (BIO) and other organizations, including Infectious Diseases Society of America, Cystic Fib...

Learn More

Efforts to Control Prescription Drug Pricing Harm Collaborative Work to Advance Patient Care with Health Innovations

Elyse Blazevich, President & CEO, Colorado BioScience Association Colorado’s life sciences community and our state leaders share an unwavering commitment to improving patient lives and making sure...

Learn More

Fitzsimons Debuts White Paper on Choosing an Innovation Community, Focus on Talent

Fitzsimons Innovation Community presents a new white paper, entitled Choosing an Innovation Community, from a group of thought leaders in the Colorado bioscience and economic development communities....

Learn More

Weekly Policy Blog: FDA Guidances on 510(k) Submissions; Actuarial Review of Biomarker Testing Coverage Bill 

FDA Issues Three Guidances on Premarket Notification [510(k)] Program  On September 7, 2023, the U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) issu...

Learn More

Weekly Policy Blog: CMS Announces Drugs Subject to Price Controls Under the IRA 

On August 29, 2023, the Centers for Medicare and Medicaid Services (CMS) announced the first ten prescription drugs that will be subject to price controls in Medicare under the Inflation Reduction Act...

Learn More

Weekly Policy Blog: CBSA and Partners Provide Recommendations to Improve CMS’ Transitional Coverage for Emerging Technologies (TCET) Proposal 

CBSA advocates for policies that improve patient access to life-saving novel technologies. This week, CBSA signed on to a letter responding to the long-awaited proposed Transitional Coverage for Emerg...

Learn More

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision New Partnership Will Accelerate Delivery of Lab Space to Market AURORA, Colo. (August 24, 2023) – Fitzsimons Innovation...

Learn More

Growing Colorado’s Promising Startups: Innosphere Ventures

Fort-Collins-based Innosphere Ventures began making an impact for Colorado’s early-stage companies a quarter-century ago. The organization’s focus is to support the business development of early-stage...

Learn More

Weekly Policy Blog: PDAB Releases Stakeholder Engagement Guide on Affordability Review Process

As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request thei...

Learn More

Weekly Policy Blog: PDAB Selects Drugs for Affordability Reviews

On Friday, August 4, the Colorado Prescription Drug Affordability Board (PDAB) selected five drugs for affordability reviews: Enbrel, Genvoya, Cosentyx, Stelara, and Trikafta. PDAB staff plan to begin...

Learn More

A Pioneering Spirit: Female Leaders Advancing Innovation

Making Colorado a leading location for health innovation requires visionaries, risk takers, problem solvers, and program builders. Women hold these pivotal roles in our state, guiding major institutio...

Learn More

Forging the Life Sciences Frontier

Colorado has one of the best talent pools in the United States, top-tier research institutions, a major international airport, a favorable tax climate, a mountain-enhanced quality of life, and support...

Learn More

Weekly Policy Blog: Congressional Activity Before August Recess

Congress moved forward with its efforts to address drug shortages, drug pricing, pharmacy benefit managers (PBMs), and transparency ahead of the August recess. This policy post covers the discussion d...

Learn More

Fitzsimons Innovation Community - Building a Life Sciences Pipeline: Room to Grow

For the past few months, the Fitzsimons Innovation Community blog has been focused on how and why Colorado is such a great home for growing life sciences organizations. This month’s topic is the benef...

Learn More

Weekly Policy Blog: PAHPA Reauthorization Advances Without Government Price Fixing

Congress took important action on pandemic preparedness last week, advancing the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bills in both the Senate and the House ahead of its e...

Learn More

Weekly Policy Blog: Drug Pricing and Affordability Update

Drug pricing and affordability continue to be key issues at both the state and federal levels as new legislation is considered and implementation of legislation that has already passed is underway....

Learn More

Weekly Policy Blog: Ethylene Oxide – EPA’s Proposed Rules 

Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways. It is one of the most common and proven ways to sterilize medical devices. EtO’s proven effectiveness means t...

Learn More

Weekly Policy Blog: Federal Update- Four New Pieces of Legislation Introduced

CBSA advocates for policies that allow patients to receive access to critical life-saving novel technologies. We applaud members of Colorado’s Congressional delegation for supporting patient access to...

Learn More

Fitzsimons Innovation Community – Building a Life Sciences Pipeline: Life Sciences Leadership

Fitzsimons Innovation Community’s monthly blog, Building a Life Sciences Pipeline, explores life sciences leadership and the connectivity that exists between Colorado’s research, healthcare, and innov...

Learn More

CBSA Advocates for Medicare Coverage of Emerging Technologies

Weekly Policy Blog: CBSA Advocates for Medicare Coverage of Emerging Technologies CBSA advocates for policies that improve patient access to critical life-saving novel technologies. The bipartisan Ens...

Learn More

Federal Funding for Health Innovation: NCI and BARDA Council of State Bioscience Associations Summer Meeting Presentations

During the Council of State Bioscience Associations' (CSBA) annual Summer Meeting, (National Cancer Institute) NCI and Biomedical Advanced Research and Development Authority (BARDA) pre...

Learn More

Fitzsimons Innovation Community – Building a Life Sciences Pipeline: Talent

Fitzsimons Innovation Community’s monthly blog, Building a Life Sciences Pipeline, looks at the intangibles that attract top life sciences talent to Colorado. A Destination for Work and Play The state...

Learn More

Join CBSA for Diversity, Equity, and Inclusion Workshops in June + July

CBSA is committed to advancing Diversity, Equity, and Inclusion (DEI) in Colorado's life sciences community to help everyone find their place in our life sciences ecosystem, build diverse and inclusiv...

Learn More

Weekly Policy Blog: CBSA Strongly Urges Congress to Enact Legislation to Modernize Diagnostic Testing

For years, Congress has been urged by a growing coalition of state life sciences associations, patient groups, and other stakeholders, to enact legislation that will modernize the Food & Drug Admi...

Learn More

Boettcher Foundation Awards $1.88 Million in Biomedical Research Grant Funding to Colorado Researchers

Foundation announces 2023 Class of Boettcher Investigators DENVER, May 25, 2023 — Boettcher Foundation today announced the 2023 class of Boettcher Investigators—eight top Colorado researchers selected...

Learn More

Colorado BioScience Association Welcomes New Appointees to Board of Directors

Robin Harper Cowie of Biodesix, Inc. and Lyndsey Linke of SiVEC Biotechnologies, Inc. Represent the Momentum of State’s Life Sciences Community Denver – Colorado BioScience Association (CBSA), which c...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients + Celebrates Program Renewal

Colorado Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Assoc...

Learn More

CBSA Hosts Annual All Member Meeting + Networking Event

Colorado BioScience Association hosted its annual All Member Meeting + Networking Event Thursday, May 11, at the St. Julien Hotel in Boulder. The vibrant event brought together members and our communi...

Learn More

Weekly Policy Blog: CBSA Urges Congress to Repeal R&D Amortization and Restore Immediate R&D Expensing

Colorado BioScience Association (CBSA) continues our work to advocate for U.S. tax policies that enable investment in critical life-saving innovation and to generate strengthened support for restorati...

Learn More

Weekly Policy Update: Legislative Session Closes Today

The 2023 legislative session, the First Regular Session of the 74th General Assembly closes today, Monday, May 8th, the 120th day of session.  During the final weeks of session, the CBSA team, th...

Learn More

Fitzsimons Innovation Community – Building a Life Sciences Pipeline: Environment

Calling Colorado’s Life Sciences Economy Home Fitzsimons Innovation Community companies choose Colorado as a home for many reasons, and the sunshine and skiing are further down on the list than you mi...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2023 Cohort

For Immediate Release: April 26, 2023 Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2023 Cohort Denver...

Learn More

Weekly Policy Blog: PDAB Bill & Biomarker Bill Updates 

CBSA's Policy + Advocacy team continues to focus on policy priorities critical to our ecosystem in the remaining weeks of the Colorado legislative session. With just over two weeks left, CBSA has take...

Learn More

Weekly Policy Blog: CBSA’s 2023 Medical Device Symposium

On April 13, CBSA members and MedTech leaders gathered at the annual Colorado BioScience Association Medical Device Symposium to discover emerging and cutting-edge trends in medical breakthroughs, gai...

Learn More

CBSA Hosts Annual Medical Device Symposium

Innovative medical technologies are transforming patient care around the world and MedTech in Colorado is growing strong with more than 2,200 devices in development or distribution. Many of the most p...

Learn More

Weekly Policy Blog: CBSA Testifies in Support of HB23-1260

CBSA is proud to advocate for a pro-business environment that supports life sciences innovation through our Policy + Advocacy leadership. CBSA Vice President and Counsel for Policy + Advocacy, Amy Goo...

Learn More

Fitzsimons Innovation Community – Building a Life Sciences Pipeline: Access to Capital

In Fitzsimons Innovation Community’s blog series, Building a Life Sciences Pipeline, hear how the CU Healthcare Innovation Fund provided strategic value for Arrive Health, and how they’ve been success...

Learn More

Weekly Policy Blog: CBSA Advocates for Return of Immediate R&D Expensing

CBSA is working to generate support for the bipartisan American Innovation & Jobs Act of 2023 (S. 866), sponsored by Senators Maggie Hassan (D-NH) and Todd Young (R-IN). This federal bill, which w...

Learn More

Colorado BioScience Association Releases 2023 Peak Talent Report

38,000 Highly Skilled Life Sciences Workers Support State’s Thriving Life Sciences Ecosystem DENVER, March 30, 2023 — Colorado BioScience Association (CBSA) announces its comprehensive new report, Pea...

Learn More

Weekly Policy Blog: Teacher Externship Program for STEM Disciplines (HB23-1198)

CBSA supports HB23-1198, Teacher Externship Program for Science Technology Engineering and Math (STEM) Disciplines, a bill sponsored by Representative Brianna Titone. It requires the Colorado Departme...

Learn More

Weekly Policy Blog: CBSA’s 2023 Day at the Capitol

On March 17, CBSA’s annual Day at the Capitol event returned in person. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which h...

Learn More

Weekly Policy Blog: PDAB Bill Advances, Plus CBSA Advocates on Federal Issues

On March 10, CBSA testified in the House Health and Insurance Committee in opposition to HB23-1225, Extend And Modify Prescription Drug Affordability Board (PDAB). While CBSA shares the bill sponsors’...

Learn More

Fitzsimons Innovation Community - Building a Life Sciences Pipeline: Cell and Gene Therapy Momentum

Ideas become cures when academia and industry connect. Human or animal cells on blue background. Concept Early stage embryo Medicine scientific concept, Stem cell research and treatment, 3D illustrati...

Learn More

Weekly Policy Blog: Governor Polis' Healthcare Legislative Package

On March 2, Governor Jared Polis held a press conference to announce a legislative package that he says will save people money on healthcare and increase transparency within the healthcare system. He...

Learn More

Weekly Policy Blog: HELP Copays Act (H.R. 830)

On February 6, 2023, the federal Help Ensure Lower Patient (HELP) Copays Act (H.R. 830) was reintroduced in the U.S. House of Representatives by Representative Earl “Buddy” Carter (R-GA) and referred...

Learn More

Weekly Policy Blog: COVID-19 Public Health Emergency to Terminate on May 11

On February 9, the Department of Health and Human Services (HHS) Secretary Xavier Becerra announced that the federal Public Health Emergency (PHE) for COVID-19 will expire at the end of the day on May...

Learn More

Colorado Life Sciences Incubation Program

The Colorado Life Sciences Incubation Program offers startups who are developing or commercializing technologies, products, devices, and life-saving breakthroughs the combined expertise and insights o...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce 2023 Colorado Life Sciences Incubation Program

State Funding from an Advanced Industries Business Accelerator Grant Supports Program DENVER, February 15, 2023 — Innosphere Ventures, Colorado BioScience Association (CBSA), and Colorado BioScience I...

Learn More

Weekly Policy Blog: CBSA Supports Drug Coverage for Serious Mental Illness Bill (HB23-1130)

CBSA supports HB23-1130, a bill that aims to help people suffering from a serious mental illness by addressing private payers’ step therapy requirements and Medicaid’s Preferred Drug List review proce...

Learn More

CBSA President & CEO Elyse Blazevich Honored by the Denver Business Journal

Congratulations to CBSA President and CEO Elyse Blazevich! The Denver Business Journal named Elyse to its prestigious 40 Under 40 List, released this week. The DBJ names a class of 40 Under 40 each ye...

Learn More

Fitzsimons Innovation Community: Building a Life Sciences Pipeline

The life sciences ecosystem in Colorado has experienced tremendous growth over the past decade, and the momentum will continue to build. The region is on a trajectory to crack the top five innovation...

Learn More

Weekly Policy Blog: CBSA Supports Biomarker Testing Coverage Bill (HB23-1110)

CBSA is supporting HB23-1110, an important bill introduced in Colorado this year that would require insurance coverage for biomarker testing supported by nationally recognized clinical practice guidel...

Learn More

Weekly Policy Blog: SB23-066 Advanced Industry Acceleration Programs Heads to First Committee

CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Accelerator Grant Programs this session through SB23-066, working with our advanced industries partners and Colorado’s...

Learn More

Fitzsimons Innovation Community Sees Record Momentum and Breakthroughs

Fitzsimons Innovation Community recently released its Second Annual Innovation Report, Discoveries Meet Momentum, focusing on the Community momentum that allows innovators to take their discoveries an...

Learn More

Weekly Policy Blog: Governor Polis’ 2023 State of the State Address

Governor Jared Polis gave his 2023 State of the State address to the Colorado General Assembly on Tuesday, January 17th, where he laid out his goals for his second term: “When Colorado reaches our 150...

Learn More

Weekly Policy Blog: Start of the 2023 Colorado Legislative Session

Colorado’s 2023 legislative session kicked off on Monday, January 9th, with swearing in, certification of election results, and opening day speeches from legislative leaders. Governor Jared Polis took...

Learn More

Weekly Policy Blog: CBSA Releases 2022 Policy + Advocacy Report

CBSA leads Policy + Advocacy to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in our ecosy...

Learn More

Colorado BioScience Institute Unveils New Brand and Website

Energetic Identity Emphasizes Investment to Cultivate and Diversify State’s Life Sciences Workforce, From Classroom, to Campus, to Career. Denver – Colorado BioScience Institute (The Institute) today...

Learn More

Weekly Policy Blog: $1.7 Trillion Omnibus Spending Package Signed into Law

Updated on 1/3/2023 President Biden signed a $1.7 trillion omnibus spending package into law on December 29th, narrowly averting a government shutdown.  In his tweet announcing this news, the Pre...

Learn More

Cutting-Edge Discoveries In Action

Fitzsimons Innovation Community members are working on world-changing developments in bioscience and healthcare, and they’re doing it in workspace customized to their projects. It’s been a remarkable...

Learn More

Introducing Amy Berenbaum Goodman

Colorado BioScience Association is thrilled to welcome Amy Berenbaum Goodman to our team in a newly expanded role, Vice President and Counsel for Policy + Advocacy.  Amy Berenbaum GoodmanVice Presiden...

Learn More

Colorado BioScience Association Welcomes Amy Berenbaum Goodman as Vice President and Counsel for Policy + Advocacy

Goodman to Advance Federal and State Policies that Support Life Sciences Innovation Denver – Colorado BioScience Association (CBSA) announces the appointment of Amy Berenbaum Goodman as Vice President...

Learn More

Colorado Life Sciences Companies Raise $1.6 Billion in 2022

Researchers and Startups Received Increased Funding from Federal Grants and Pre-Seed/Seed Rounds DENVER – Colorado BioScience Association today announced annual fundraising totals for the state’s life...

Learn More

New Data on Prescription Drug Prices and Inflation

Prescription drug prices lag inflation, according to new information from the Altarum November 2022 Health Sectors Economic Indicators Briefs. With inflation top of mind for policymakers at the state...

Learn More

Vital Transformation Study Examines New Proposals to Alter Accelerated Approvals

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team continues to monitor and review legislation that could directly affect life sciences...

Learn More

Fitzsimons Innovation Community Wins CBSA Building Momentum Award

CBSA Building Momentum Award Announcement Fitzsimons Innovation Community is the inaugural recipient of the Colorado BioScience Association’s new Award: Building Momentum. This award recognizes invest...

Learn More

CBSA Urges Passage of PASTEUR Act During Lame Duck Session

CBSA urges Congress to pass important legislation, the Pioneering Antimicrobial Subscriptions to End Up-Surging Resistance Act (PASTEUR Act) during the “lame-duck” session. There is limited time to pa...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado’s Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Associat...

Learn More

Colorado BioScience Association Recognizes Legislators of the Year at 19th Annual Awards Celebration

Colorado BioScience Association (CBSA) recognized two state legislators for their leadership on issues critical to life sciences at the 19th Annual Awards Celebration Presented by AGC Biologics on Nov...

Learn More

Colorado BioScience Association Celebrates the Momentum in State’s Life Sciences Community at 19th Annual Awards Celebration: BioIntelliSense Named Company of the Year, Enveda Biosciences Honored as Rising Star

Denver, November 17, 2022 – Colorado BioScience Association celebrated the Colorado companies, organizations, and individuals who are building momentum for Colorado’s life sciences community with thei...

Learn More

Weekly Policy Update: Key Takeaways from the 2022 Midterm Election

In Colorado State races, Democrats prevailed across the state. In fact, Democratic leaders expanded their political power and won by wide margins in all the statewide races. They increased their alrea...

Learn More

Remembering Colorado House Minority Leader Hugh McKean, an Advocate for Colorado’s Life Sciences Ecosystem

Colorado BioScience Association (CBSA) sends our condolences to the family, friends, and colleagues of Representative Hugh McKean, the Colorado House Minority Leader. Our team and board are deeply sad...

Learn More

Colorado BioScience Association to Recognize Outstanding Companies and Leaders at Annual Awards Celebration

Aktiv Pharma Group, BioIntelliSense, and Umoja Biopharma Selected as Finalists for Company of the Year; Enveda Biosciences, Think Bioscience, and Watchmaker Genomics Honored as Finalists for Rising St...

Learn More

Weekly Policy Update: Recent State Budget Forecasts

CBSA monitors budget forecasts to assess how the economy, overall employment, and state revenue forecasts could impact CBSA’s State Policy Priorities and our Policy + Advocacy strategy for the upcomin...

Learn More

Elevation Diagnostics Supports People and the Planet with Precision Testing

Elevation Diagnostics addresses the growing demand for fast, accurate diagnostic testing in our community. With our flagship location at Fitzsimons Innovation Community, we are committed to providing...

Learn More

Weekly Policy Update: President Biden Signs New Drug Pricing Executive Order

President Biden signed an Executive Order on Friday, October 14th directing Health and Human Services (HHS) to explore additional actions to lower prescription drug costs. This order is on top of...

Learn More

Weekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)

The Centers for Medicare & Medicaid Services (CMS) are currently working to develop a new rule that could provide Medicare patients faster access to innovative, lifesaving, and life-enhancing medi...

Learn More

Weekly Policy Blog: CBSA Continues Engagement on the WTO TRIPS Waiver

In a few months, member states of the World Trade Organization (WTO) will decide whether to expand the TRIPS waiver to include COVID-19 therapeutics and diagnostics. Colorado BioScience Association is...

Learn More

Victories for Innovation: Congress Reauthorizes the SBIR/STTR and User Fee Programs

CBSA celebrates policy victories for Colorado's life sciences community and America’s innovators, scientists, and entrepreneurs. Congress reauthorized critical SBIR/STTR and User Fee programs. Without...

Learn More

Fitzsimons Innovation Community Companies Demonstrate Momentum

Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcas...

Learn More

Weekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)

President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...

Learn More

CBSA Remains Active on the Critical Need to Reauthorize Vital SBIR/STTR Programs for Life Sciences

Act Today and Tell Your Member of Congress to Support Vital SBIR/STTR Programs for Life Sciences The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs ar...

Learn More

Weekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact

The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...

Learn More

Colorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference

Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at t...

Learn More

Weekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting

On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...

Learn More

InVitria’s Technology Eliminates Risks and Protects Patients

InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in...

Learn More

Weekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health

Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...

Learn More

Colorado BioScience Association Appoints Emily Martini as Vice President, Partnerships

Martini to Lead Strategic Partnerships, Initiatives, and Programs in Newly Created Role Denver – Colorado BioScience Association (CBSA) announces the appointment of Emily Martini as Vice President of...

Learn More

Weekly Policy Blog: President Biden Signs Inflation Reduction Act into Law

On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...

Learn More

Weekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements

CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....

Learn More

CBSA Remains Active on Critical Federal Legislation

Act Today and Tell Your Member of Congress: Oppose Government Price Setting Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language t...

Learn More

Weekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives

Congress is negotiating sweeping legislation that impacts life sciences. Colorado BioScience Association (CBSA) remains active on these important legislative proposals, which include supporting the re...

Learn More

Fitzsimons Innovation Community Invests to Meet Market Needs

Fitzsimons Innovation Community has maintained a fast pace of development over the past 10 years, building capacity to meet market needs. With an increase in the demand for move-in ready life sciences...

Learn More

Weekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to advance high-...

Learn More

Weekly Policy Update: Where We Stand Today on Reauthorization of SBIR/STTR

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to help advance...

Learn More

Weekly Policy Update: CBSA Urges Repeal of Harmful R&D Amortization Provision

Earlier this month, Colorado BioScience Association (CBSA) partnered with Biotechnology Innovation Organization (BIO) and sent a letter to Congress urging immediate legislative action to repeal the ha...

Learn More

Invenux Accelerates Solutions for the Future of Rare Disease Patients

Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a...

Learn More

Manager’s Amendment in FDA Safety and Landmark Advancements (FDASLA) Act Would Include and Allow Drug Importation

Earlier this month, Colorado BioScience Association (CBSA) engaged on the U.S. Food and Drug Administration’s (FDA) Safety and Landmark Advancements (FDASLA) Act. CBSA and our national partners suppor...

Learn More

Weekly Policy Update: CBSA Engages on FDA Safety and Landmark Advancements (FDASLA) Act

Colorado BioScience Association (CBSA) and our national partners support the critically important reauthorization of the U.S. Food and Drug Administration’s (FDA) prescription drug, generic drug, bios...

Learn More

Colorado Governor Jared Polis Signs Reauthorization and Expansion of Advanced Industries Tax Credit Into Law

Colorado BioScience Association thanks Governor Jared Polis for signing the Advanced Industries Tax Credit, House Bill 1149, into law. “This legislation supports the incredible breakthroughs driving C...

Learn More

Colorado BioScience Association Applauds the 2022 Class of Boettcher Investigators

Boettcher Foundation awards $1.88 million in biomedical research grant funding to Colorado researchers DENVER, June 1, 2022 — Colorado BioScience Association (CBSA) congratulates the 2022 class of Boe...

Learn More

Validus Cellular Therapeutics Gains Momentum in Cellular Therapy

Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for on...

Learn More

Weekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs Update

A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...

Learn More

Historic $200 Million Commitment to the University of Colorado Anschutz Medical Campus Fuels Advancements in Treatments and Cures

The University of Colorado Anschutz Medical Campus today announced the creation of the Gates Institute, a state-of-the-art facility that will focus on rapidly translating laboratory findings...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2022 Cohort

Early-Stage Companies in Biotech, Medical Device, Oral Health/Teledentistry, and Health Technology Selected to Take Part in Year-Long, State-Funded Program Denver and Fort Collins, Colo.- Innosphere V...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado’s Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Associat...

Learn More

Weekly Policy Update: Legislative Session Closes – CBSA Reviews Policy Accomplishments

The 2022 legislative session, the Second Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that  began with the legislature having significant financial...

Learn More

State Tax Credit Expanded: A Win for Our Community

CBSA is pleased to share news of a significant win at the State Capitol for our life sciences community. Late last night, the legislature voted to reauthorize the Advanced Industries Tax Credit Progra...

Learn More

Weekly Policy Update: Legislative Session Enters the Final Weeks

The legislative session is scheduled to end on Wednesday, May 11th, or in about 12 days. As we enter the final stretch, the CBSA team continues to weigh in on key legislation and advocate on behalf of...

Learn More

Atara Biotherapeutics Fosters Hope for Those Impacted by Cancer, Autoimmune Diseases

Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumor...

Learn More

What is Happening in Life Sciences Valuations?

Guest Post by Peter Adams, Executive Director, Rockies Venture Club Anyone who has been watching valuations in life sciences deals over the past couple of years knows that median valuations in life sc...

Learn More

Colorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors

Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Terumo Blood and Cell Technologies Join Board Denver – Colorado BioScience Association (CBSA), which cre...

Learn More

Weekly Policy Update: Congressional Tax Package Could Support Further Industry Growth

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More

Why Do So Many Angel/VC Investors Misunderstand Life Sciences Investing?

Guest Post by Peter Adams, Executive Director, Rockies Venture Club I am often surprised when I meet investors who claim that they invest in just about anything but life sciences.  Last year heal...

Learn More

Weekly Policy Update: Medical Device User Fee Amendments (MDUFA)

CBSA and our national partners support the renewal of the critically important Medical Device User Fee Amendments (MDUFA). After months of negotiations among the FDA and industry advocacy groups, incl...

Learn More

Weekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs

A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...

Learn More

Weekly Policy Update: TRIPS Waiver Update

Colorado BioScience Association continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver, due the harmful precedent the waiving of IP...

Learn More

CBSA Thanks AGC Biologics, Our Sustaining Sponsor

Thank you to CBSA Sustaining Sponsor, AGC Biologics! AGC Biologics deepened its investment in CBSA and Colorado’s life sciences ecosystem with our highest level of sponsorship. We are thrilled by the...

Learn More

Greffex Transforms Vaccine and Gene Therapy Work

Greffex™ is a privately held, multi-national company that developed a novel genetic platform for the development and production of vaccines. The GREVAX™ Universal Platform delivers vaccines in a faste...

Learn More

Weekly Policy Update: Advocacy on Congressional Tax and Investment Policies

Colorado BioScience Association is watching legislative proposals at the federal level that would be harmful to business. These proposals would have impacts on Qualified Small Business Stock and tax c...

Learn More

Weekly Policy Update: Accelerated Approvals Reform Bill Introduced

CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...

Learn More

Support Needed: Colorado Coalition’s Application for the Build Back Better Grant

Colorado BioScience Association is asking for your support. The Colorado Coalition, which includes CBSA, is working to secure up to $100 million in funding for life sciences and cleantech in our state...

Learn More

Weekly Policy Update: President Biden Delivers First State of the Union Address

Earlier this week, President Biden delivered his first State of the Union address as President to a joint session of Congress. While the speech was primarily focused on the conflict in Ukraine, the Pr...

Learn More

Colorado Life Sciences Incubation Program: New Program for Colorado-Based Startups

Colorado BioScience Association is proud to launch a new incubation program for early-stage companies in partnership with Innosphere and our sister organization, Colorado BioScience Institute. The yea...

Learn More

LabXchange Provides Value: Colorado BioScience Institute and Amgen Foundation Support Teacher Trainings in Colorado

Through the generous support of the Amgen Foundation, the Colorado BioScience Institute collaborates with Harvard University’s LabXchange to provide teacher trainings in Colorado. LabXchange sat down...

Learn More

Weekly Policy Update: HB22-1149 Advanced Industries Investment Tax Credit Heads to First Committee

CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Investment Tax Credit this session through HB22-1149. The bill is sponsored by Rep. Shannon Bird, Rep. Mike Lynch, and...

Learn More

Colorado Research Partners Cultivates Future of Fructose Inhibitors

Colorado Research Partners is a pharmaceutical company in the Fitzsimons Innovation Community that brings enthusiasm to curbing the effects of nonalcoholic fatty liver disease using their fructose inh...

Learn More

Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

During our annual Day at the Capitol event, members heard about CBSA's state advocacy efforts and the issues impacting Colorado's life sciences ecosystem this legislative session. Lieutenant Governor...

Learn More

Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce New Incubation Program to Grow Life Sciences Startups

State Funding from Advanced Industries Business Accelerator Grant to Support Program DENVER, February 17, 2022 — Innosphere Ventures, Colorado BioScience Association (CBSA), and Colorado BioScience In...

Learn More

Weekly Policy Update: State Regulation of Ethylene Oxide

The regulatory environment regarding the usage of Ethylene Oxide (EtO) for the sterilization of medical devices is constantly evolving. Colorado state legislators are drafting a proposal that would cr...

Learn More

Weekly Policy Update: Biden Administration Relaunches “Cancer Moonshot”

Earlier this week, President Biden relaunched the Cancer Moonshot initiative which was originally created while he was serving as Vice President in 2016. And today also happens to be World Cancer Day...

Learn More

The Colorado BioScience Institute and St. Vrain Valley Schools Receive $435,200 Grant to Advance Workforce Pathways

FREDERICK, Colorado – The Colorado BioScience Institute and St. Vrain Valley Schools have been awarded a $435,200 Workforce Innovation Grant from the Weld County Workforce Development Board in su...

Learn More

Weekly Policy Update: State Opioid Fee

CBSA is tracking the development of a policy proposal from legislators that would mandate a fee on opioid manufacturers and distributors, along with manufacturers of other controlled substances includ...

Learn More

Fitzsimons Innovation Community Bioscience 5 Development Officially Underway

Fitzsimons Innovation Community is making progress on the buildout of their newest bioscience facility, for cell and gene therapy. With Fitzsimons Innovation Community and CU Anschutz Medical Campus i...

Learn More

Weekly Policy Update: Medicaid's 340B Program

As the General Assembly wraps up its second week back in session, the Colorado BioScience Association is tracking the development of a policy proposal from legislators that could have significant impa...

Learn More

Weekly Policy Update: Start of the Colorado Legislative Session

The Colorado State Legislature returned this past Wednesday to start the second regular session of the 73rd General Assembly. Even before the legislature’s return, Colorado BioScience Association has...

Learn More

Weekly Policy Update: December State Budget Forecast

In December, the Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented strong budget forecasts which are a positive sign for the state’s...

Learn More

CBSA President and CEO Is Recognized in Colorado Inno as a Top Tech Hire 2021

CBSA President and CEO, Elyse Blazevich, has been recognized in Colorado Inno as a top tech hire. Elyse strategically advances CBSA’s work to build a pro-innovation environment for life sciences in Co...

Learn More

CBSA Champions Life Sciences in 2021 with End of Year Highlights

Colorado’s reputation as a leading location for health innovation continues to accelerate. In 2021, we broke the top 10 in a new ranking of top North American life sciences hubs, climbing to #8. We ac...

Learn More

Weekly Policy Update: Build Back Better Act Stalled in the Senate

Over the weekend Democratic Senator Joe Manchin of West Virginia announced that he would be voting ‘no’ on the Build Back Better Act (BBBA). His concerns with the legislation are primar...

Learn More

Weekly Policy Update: FDA Commissioner Nominee Confirmation Hearing

Last month, President Biden announced Robert Califf, M.D. as his nominee for Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s confirmation hearing was held this week by the Senate...

Learn More

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021

Major IPOs, Venture Capital Funding, and Government Funding Accelerate Health Innovation DENVER – Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing comm...

Learn More

Essent Biologics and Amnion Foundation Partner to Provide Germinal-Origin Cells to Further Drug Discovery and Regenerative Medicine Research

Distribution Agreement Will Allow Access to Innovative Full-Term Placenta-Derived Cells to Support Ground-Breaking Research Centennial, Colo. — December 14, 2021 — Essent Biologics™, a leading supplie...

Learn More

Weekly Policy Update: Business Implications from Pending Legislative & Regulatory Activities + CBSA USPTO Roundtable

In addition to the ongoing conversations in the Senate related to the House of Representatives’ version of the $1.75 trillion Build Back Better Act (BBBA), the federal government will be seeking stric...

Learn More

Weekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments Remains Under Consideration by the World Trade Organization

CBSA continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver. Our monitoring of the waiver is due the harmful precedent waving of IP...

Learn More

Pathways Bioscience Seeks to Optimize Aging

Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging. By use of a dietary supplement with naturally occurring plant-based ingredients,...

Learn More

Weekly Policy Update: World Antimicrobial Awareness Week + Cures 2.0 & PASTEUR Act

World Antimicrobial Awareness Week, hosted by the World Health Organization last week, focused on increasing awareness of global antimicrobial resistance (AMR). and encou...

Learn More

CBSA Applauds Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association applauds CBSA members and honorees from across our state's innovation ecosystem who were awarded Advanced Industries Accelerator Grants by Colorado’s Office of Economic...

Learn More

Weekly Policy Update: Qualified Small Business Stock Implications within the Build Back Better Act

In addition to the price-setting policies and investment implications related to the capital gains tax rate and IRA provisions, the House version of the Build Back Better...

Learn More

Weekly Policy Update: CBSA Hosts Ecosystem Briefing and Roundtable Discussion with Belgian Ambassador Jean-Arthur Régibeau

This week, CBSA was honored to host a dynamic briefing and roundtable discussion for Belgian Ambassador Jean-Arthur Régibeau. Our community appreciated the opportunity to...

Learn More

Bond Pet Foods Develops The World's First Animal-Free Chicken Protein For Dog And Cat Nutrition

Proprietary approach brews chicken protein through biotechnology and fermentation, instead of harvesting conventionally on farm and field Bond Pet Foods, Inc., the Boulder-based company working with b...

Learn More

CBSA Website Wins National Award

The Colorado BioScience Association website recently received national recognition by the w3 Awards organization, which celebrates digital excellence. Our site was honored in the industry association...

Learn More

Weekly Policy Update: Agreement Reached on Drug Pricing Policies within the Budget Reconciliation Package

Late last week, the White House released a framework for the budget reconciliation package, known as the Build Back Better Act. The original package had a total cost of $3.5 trillion. The latest frame...

Learn More

Weekly Policy Update: New CBSA President & CEO Brings Direct Experience with State and Federal Policy Priorities

The CBSA Board of Directors announced the appointment of Elyse Blazevich as our President & CEO on October 27. The Association is fortunate to have som...

Learn More

Colorado BioScience Association Appoints Elyse Blazevich, Medical Device Company Founder and Business Leader, as President & CEO

Blazevich Steps into New Role During Period of Significant Momentum for Life Sciences in Colorado Denver – Colorado BioScience Association (CBSA) announces the appointment of medical device company fo...

Learn More

Weekly Policy Update: Medicare Coverage of Innovative Technology (MCIT) Pathway

The Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) submitted comments last week to the Centers for Medicare...

Learn More

ClearSight Seeks to Restore Vision and Improve the Quality of Life for Millions

ClearSight is developing innovative solutions for ophthalmologists that aim to change the standard of care for many patients. Utilizing a micropattern and patented design, the first intraocular lens C...

Learn More

Weekly Policy Update: Legislators of the Year Announced + TRIPS Waiver Update

Legislators of the Year  CBSA recognized four state legislators for their leadership on issues critical to life sciences, earlier this week at the Innovation Forward Forum + Awards Cele...

Learn More

Colorado BioScience Association Recognizes Legislators of the Year at Innovation Forward: Forum + Awards Celebration

Four State Legislators Honored for their Leadership on Issues Important to Life Sciences Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the  Innovat...

Learn More

Colorado BioScience Association Highlights Health Innovators at Innovation Forward: Forum + Awards Celebration

LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored as Rising Star of the Year Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the ...

Learn More

Life Sciences Companies Pitch at Innovation Forward: Forum + Awards Celebration on October 12 for $7,500 Prize

Colorado BioScience Association is excited to welcome our life sciences ecosystem back to in-person education + networking. We’re planning the largest gathering of our community since early 2020. We a...

Learn More

Weekly Policy Update: Tax and Investment Implications within the Budget Reconciliation Package

In addition to the price-setting policies from H.R. 3, which are already included in House Democrats' version of the 10-year, $3.5 trillion spending plan, two tax policies along with ch...

Learn More

Zalgen Labs Develops and Deploys Solutions to Emerging Viral Threats

Zalgen Labs is making a difference for patients around the world with solutions to viral threats and neglected tropical diseases. They specialize in the design and production of superior biological mo...

Learn More

Weekly Policy Update: State Budget Forecast

The Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented similar budget forecasts during their quarterly presentations to the...

Learn More

Weekly Policy Update: Congressional Drug Pricing Effort Advances

House Democrats are in the process of including the policies contained within H.R. 3 into their 10-year, $3.5 trillion spending plan that they hope to pass using the budget reconciliation process.  Cu...

Learn More

Colorado BioScience Association to Celebrate Leading Life Sciences Companies at Awards Celebration

LightDeck Diagnostics, Proov, and OnKure Named as Company of the Year Finalists; Artisan Bio, Enveda Biosciences, and Foresight Diagnostics Named Rising Star of the Year Finalists Denver – Colorado Bi...

Learn More

Weekly Policy Update: Biden Administration Releases Drug Pricing Plan

The Biden Administration through the Department of Health and Human Services (HHS) published a white paper detailing multiple policy strategies to address prescription drug costs, the paper is in resp...

Learn More

Weekly Policy Update: New Survey Provides Limited Insight into Coloradans' views on Healthcare

Consumers for Quality Care (CQC) who state they are a coalition of advocates and former policymakers working to provide a voice for patients in the health care debate as they demand better care, relea...

Learn More

GelSana Therapeutics Provides Breakthrough in Hydrogel Technology

GelSana Therapeutics, Inc. is fabricating next-generation wound healing hydrogels that offer faster healing with less inflammation, especially for chronic wounds such as diabetic ulcers. The GelSana t...

Learn More

Weekly Policy Update: Congressional Drug Pricing Efforts + CBSA Medical Device Symposium

H.R. 3 Impact House Speaker Nancy Pelosi originally released H.R 3, the Lower Drug Costs Now Act in 2019, the Act went on to pass out of the chamber by a slim bipartisan margin where it then faced pre...

Learn More

Colorado BioScience Association Announces Appointment of Vice President

Michael Crews to Advocate for Life Sciences Priorities at the State and Federal Level DENVER – Colorado BioScience Association (CBSA) today announced a key hire, new Vice President Michael Crews. Crew...

Learn More

Weekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments still under consideration by the World Trade Organization

Earlier this year the Colorado BioScience Association (CBSA) along with 300 other global biotechnology companies and associations signed onto a declaration outlining the harm of a proposed waiver of t...

Learn More

Weekly Policy Update: CBSA Applauds Senator Bennet’s Leadership on Early Cancer Detection Legislation

Last week, Colorado U.S. Senator Michael Bennet hosted a roundtable discussion on his Medicare Multi-Cancer Early Detection Screening Coverage Act. Kathleen (Kiki) Traylor, M.D., State Affairs Directo...

Learn More

CBSA Applauds Rep. Jason Crow for Supporting Health Innovation in Our State

Colorado BioScience Association (CBSA) applauds Representative Jason Crow (D-CO) for re-introducing the Small Business Innovation Voucher Act with Representative Tim Burchett (R-TN). This bipartisan l...

Learn More

CBSA Presents on Thriving Life Sciences Community to ACE Delegation

Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. Last week, CBSA’s President and CEO Jennifer Jones Paton presented at a session of The ACE 13 ev...

Learn More

Event Series The Leader Within Highlights Inspiring Stories of Leadership

In 2021, Colorado Bioscience Association and the Medtronic Women’s Network teamed up to create The Leader Within – a virtual event series to hear from local life sciences leaders in an exclusive setti...

Learn More

Weekly Policy Update: CBSA Lays Groundwork for Upcoming 2022 Session

Colorado BioScience Association (CBSA) leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal polici...

Learn More

A Message from President & CEO Jennifer Jones Paton on her Transition from CBSA

Dear Colorado Life Sciences Community, After almost five years at Colorado BioScience Association and more than two years as President & CEO, I have decided to transition from my role at CBSA to f...

Learn More

Colorado BioScience Association Announces Departure of President & CEO, Jennifer Jones Paton

Board of Directors to Begin Comprehensive Search for Replacement DENVER – Colorado BioScience Association (CBSA) announced Jennifer Jones Paton’s plans to transition from her President & CEO role....

Learn More

Policy + Advocacy: End-of-Session Report

CBSA leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in o...

Learn More

A Letter from Our President & CEO

Colorado Life Sciences Community: Our ecosystem continues to demonstrate remarkable growth and innovation as we enter the second half of 2021. Medtronic broke ground on a new campus in Lafayette at th...

Learn More

Foresight Diagnostics Transforms Standard of Care for Disease Surveillance

Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify p...

Learn More

Weekly Policy Update: CBSA Signs BIO CEO Declaration on Global Access to COVID-19 Vaccines and Treatments and the Role of Intellectual Property

Colorado BioScience Association (CBSA) and close to 300 other global biotechnology companies and associations have come together in opposition to waiving IP protections for COVID-19 vaccines and treat...

Learn More

Weekly Policy Update: PASTEUR Act, COVID-19 Intellectual Property, and June Economic Forecast

CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics Last week Senator Michael Bennet introduced new bipartisan legislation in the U.S. Senate that would s...

Learn More

A Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session

Dear Colorado Life Sciences Community, Colorado BioScience Association builds a collaborative, pro-innovation environment for life sciences innovation. Through our Policy + Advocacy efforts, we work a...

Learn More

Legislative Session Closes – CBSA Reviews Policy Accomplishments

The 2021 legislative session, the First Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that started during the heights of the COVID-19 pandemic and ended...

Learn More

Join Our Team at Colorado BioScience Association

It’s an incredible time to champion life sciences. Big thinkers and bold leaders from Colorado are saving and changing lives around the world with health innovations, products, and solutions. Our comm...

Learn More

Policy Wins for Colorado Life Sciences Community with SB 175 Amendments

As the legislative session nears an end, health care and prescription drug bills are still being negotiated. Last week, Colorado SB 175 passed the House floor on a second reading on Friday. CBSA thank...

Learn More

Weekly Policy Update: Two State Bills Move Forward That Could Adversely Impact Life Sciences Ecosystem

The end of the 2021 Colorado legislative session is quickly approaching. The last possible day (June 12) is less than two weeks away and it’s possible that the General Assembly could even wrap up befo...

Learn More

Colorado BioScience Association Celebrates the 2021 Class of Boettcher Investigators

Boettcher Foundation awards $1.41 million in biomedical research grant funding to Colorado researchers Colorado BioScience Association (CBSA) congratulates six leading Coloradoresearchers who are the...

Learn More

Exxel Pharma: Small Molecule Therapy, Big Impact

Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how and experience from the pharmaceutical industry to develop medicines for significant unm...

Learn More

Weekly Policy Update: State Bills Advance to Create More Small Business Support Programs

Two state bills advanced this week that would create new programs to support Colorado small businesses. These proposals are part of a larger $800 million state stimulus package that targets aide to ce...

Learn More

CBSA Congratulates Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

Weekly Policy Update: CBSA Hosts Congressional Briefing on the Impacts of Reference Pricing

CBSA partnered with We Work for Health Colorado this week to host a briefing for Colorado congressional offices about the impacts of international reference pricing on our innovation ecosystem. Duane...

Learn More

CBSA Congratulates Emily Roberts on New Role, Launches Search for Replacement CBSA

Emily Roberts has accepted a position at CBSA member company Genentech on the issue advocacy team. CBSA congratulates Emily on this exciting next step in her career.  She has made a sig...

Learn More

Weekly Policy Update: Drug Review Board Legislation Passes State Senate

Senate Bill 175 (Prescription Drug Affordability Review Board) passed the Colorado Senate today on a vote of 19-16. The bill would create a prescription drug review board in Colorado that is charged w...

Learn More

Weekly Policy Update: Colorado Legislature Finalizes State Budget

The Colorado legislature finalized the state budget today, which will now be sent to Governor Polis for his signature. In addition to funding day-to-day operations of the state government, the $34.6 b...

Learn More

CPC Works to Propel Beyond Research, Engage Community Directly

CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific ov...

Learn More

Colorado BioScience Association Appoints New Board Members

Colorado BioScience Association (CBSA) today announced the appointment of seven new members to its board of directors, Jim Kasic, CEO of EndoShape and Chairman of Boulder IQ; Anil Mathai, Vice Preside...

Learn More

Colorado’s Life Sciences Ecosystem Achieves Record Q1 Fundraising

Colorado BioScience Association (CBSA) today announced the state’s life sciences community raised an unprecedented $704 million in the first quarter of 2021. Capital from public, private, and federal...

Learn More

CBSA Urges CMS to Implement MCIT Rule Without Delay

In January, CMS finalized a new rule called Medicare Coverage of Innovative Technologies (MCIT). The rule provides immediate national Medicare coverage for FDA-designated breakthrough devices and diag...

Learn More

Weekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities

Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...

Learn More

Your Help Needed Now: Tell Colorado Legislators to Protect Life Sciences Innovation

The Colorado state legislature is considering a bill that creates a state drug review board with the power to set payment rates for medicines in Colorado. The unelected board could set price limits wi...

Learn More

Weekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse

CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...

Learn More

Weekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal

Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...

Learn More

PhosphoSolutions Drives Scientific Breakthroughs with Research Antibodies

PhosphoSolutions specializes in producing high-quality research antibodies for the neuroscience community. The company's research antibodies provide critical information on drug effectiveness that dri...

Learn More

Weekly Policy Update: State Leaders Solicit Input on Colorado’s Stimulus Funding

Colorado and local governments are expected to receive billions of dollars from the 2021 American Rescue Plan. In an effort to better understand the needs and current economic challenges facing the st...

Learn More

Novartis Gene Therapies News

Work in Progress to Support Jobseekers and Identify New Candidates for Facility Novartis Gene Therapies, formerly AveXis, plans to wind down its Longmont facility in July. Novartis Gene Therapies has...

Learn More

Robust Speaker Line-Up and Pitch Event Winner at CBSA-Amgen Healthcare Innovation

The CBSA-Amgen Healthcare Innovation Event took place this week filled with engaging speakers and a robust audience. Thank you to our sponsors Amgen, Amgen Ventures and CBSA sustaining spons...

Learn More

Weekly Policy Update: CBSA Testifies on Local Impact of Drug Pricing Bill

This week CBSA testified in opposition to Senate Bill 175 in the Senate Health & Human Services Committee. The bill would create a prescription drug review board in Colorado that’s charged with re...

Learn More

Weekly Policy Update: CBSA Engages on Key Legislation

CBSA took new positions on several bills in the 2021 legislative session. Here is a recap of what happened this week. New Funding for Advanced Industries Grant Program: On Tuesday, the legislature pas...

Learn More

Colorado Vaccine Distribution Update

The Colorado Department of Public Health & Environment (CDPHE) confirmed to CBSA that members of our life sciences workforce involved in the research, development, manufacturing and distribution o...

Learn More

Policy + Advocacy: Legislature Passes New Funding for Advanced Industries Accelerator Grant Program

On Tuesday, the Colorado General Assembly passed Senate Bill 42, which includes a one-time, $10 million infusion for the Advanced Industries Accelerator Grant Program. Governor Polis is expected to si...

Learn More

Weekly Policy Update: CBSA Shares Survey Insights

The CBSA Policy + Advocacy team works to engage state and federal policymakers on issues that are critical to our members and Colorado’s life sciences ecosystem. Last month, CBSA conducted a survey to...

Learn More

The Colorado Molecular Correlates Laboratory Puts Quality First

The Colorado Molecular Correlates Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cance...

Learn More

Weekly Policy Update: CBSA Takes Positions on New State Legislation

The Colorado state legislature returned on February 16th to continue the 2021 session, and there have already been almost 300 bills introduced so far. CBSA’s Policy + Advocacy team has been hard at wo...

Learn More

CBSA Joins Patient Community to Raise Awareness about Rare Diseases

This week, CBSA joined the Colorado Rare Action Network for Colorado Rare Disease Day. The virtual event was an opportunity to educate state legislators and the public about the challenges rare diseas...

Learn More

Weekly Policy Update: Governor Polis Delivers the State of the State

On Wednesday, Governor Jared Polis delivered his State of the State address. He started by acknowledging the challenges Colorado and the country have faced over the past year in the midst of a global...

Learn More

Weekly Policy Update: Colorado Legislative Session Resumes Next Week

The Colorado state legislature returns next Tuesday to resume the first regular session of the 73rd General Assembly. Here are a few of the issues CBSA is focused on this session. Advanced Industries...

Learn More

Weekly Policy Update: Congressional Democrats Use Budget Reconciliation, Creating Path for COVID Relief Package

On Friday, the U.S. Senate and the U.S. House of Representatives passed a budget resolution, advancing the process of budget reconciliation that will allow Democrats to pass President Joe Biden’s COVI...

Learn More

Weekly Policy Update: Colorado Releases Solicitation to Operationalize Canadian Drug Importation Program

In 2019, the Colorado General Assembly passed SB19-005, which authorized the Department of Health Care Policy & Financing (HCPF) to seek approval from the federal government to create a Canadian d...

Learn More

Cerebral Therapeutics Advances Neurological Science and Patient Outcomes

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: President Biden Takes Immediate Action

On January 20, President Joe Biden signed a series of executive orders, just hours after taking his oath of office. In addition to reversing some of the steps taken by the Trump Administration over th...

Learn More

Weekly Policy Update: CMS Finalizes New Pathway for Medicare Coverage of Innovative Technologies

The Centers for Medicare and Medicaid Services (CMS) published a final rule this week that creates a new, voluntary pathway for immediate, national Medicare coverage for medical technologies approved...

Learn More

Weekly Policy Update: Small Business Administration Releases New Details for Paycheck Protection Program

The Small Business Administration (SBA) released new guidance this week for the next round of Paycheck Protection Program (PPP) loans. Congress authorized $284.45 billion to go towards PPP loans as pa...

Learn More

CBSA Highlights Colorado Case for U.S. International Trade Commission

CBSA submitted a letter to the U.S. International Trade Commission this week calling attention to a complaint made by Ventria Bioscience, Inc., an important member of Colorado's life sciences communit...

Learn More

Weekly Policy Update: CBSA Prepares for the 2021 Legislative Session

On January 13, the Colorado General Assembly will convene for a short time to address urgent business and then take a temporary recess, with the aim of returning to the state Capitol on February 16 to...

Learn More

Congress Passes New COVID Relief Package: What it Means for Colorado Life Sciences

Late last night Congress passed a $900 billion coronavirus aid package that will provide emergency economic relief and stimulate the nation’s economy. This is the first COVID-19 relief measure that Co...

Learn More

Neurexis Therapeutics Works to Solve an Unmet Healthcare Need

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: December Revenue Forecast Shows More Money Than Expected to Support Recovery

Today the Governor’s Office of State Planning & Budgeting and the state’s Legislative Council presented their December economic and revenue forecasts to the General Assembly’s Joint Budget Committ...

Learn More

Colorado BioScience Association Annual Awards Celebration: Video Highlights

Colorado’s life sciences community gathered on December 9 to toast the companies and organizations driving health innovation forward. CBSA President & CEO Jennifer Jones Paton and CBSA Board Chair...

Learn More

Colorado’s Life Sciences Ecosystem Raises $1.2 Billion in 2020

Leadership During COVID-19 Accelerated Interest and Investment in Colorado DENVER – Colorado BioScience Association today announced the fourth year Colorado’s life sciences community has raised more t...

Learn More

Weekly Policy Update: COVID-19 Vaccine Distribution in Colorado

The last week has been groundbreaking for science and health innovation. On Friday, December 11, the U.S. FDA granted Emergency Use Authorization (EUA) for a COVID-19 vaccine developed by Pfizer and B...

Learn More

CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics

Yesterday Senator Michael Bennet introduced new legislation in the U.S. Senate that aims to ensure timely Medicare coverage for new, innovative tests that detect multiple types of cancer before sympto...

Learn More

OEDIT Convenes State Legislators for Session on Advanced Industries

On Wednesday, the Colorado Office of Economic Development and International Trade (OEDIT) partnered with CBSA and the six other advanced industries to host an informational session for state legislato...

Learn More

Colorado BioScience Association Honors Life Sciences Leaders Driving Innovation Forward at Annual Awards Celebration

Inscripta Wins Company of the Year, Edgewise Therapeutics Named as Rising Star Denver, December 10, 2020 – Colorado BioScience Association celebrated the companies and organizations driving new health...

Learn More

Weekly Policy Update: Colorado Special Session Recap

The Colorado General Assembly met for a three-day Special Session this week to pass an economic stimulus package that provides support and relief to certain small businesses, education providers, and...

Learn More

CBSA Convenes Experts + Advocates to Discuss the Promise of Genomic Medicine

This week CBSA partnered with the Colorado Cancer Caucus and the Biotechnology innovation Organization (BIO) to host a discussion on the promise of genomic medicine for oncology and rare, genetic dise...

Learn More

Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

Weekly Policy Update: Colorado Special Legislative Session + Interim Final Rule on Most Favored Nation Payment Model

Yesterday Governor Polis called a Special Session of the General Assembly to discuss an economic stimulus package that he said cannot wait until January. The session is scheduled to begin on November...

Learn More

Global Impact: Z Biotech Advances Glycoscience Research

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Governor Presents Budget Proposal to State Legislature's Joint Budget Committee

Earlier this month, Governor Polis released his $35 billion budget proposal for fiscal year 2021-22. The request included three key elements to boost Colorado’s economy and support critical investment...

Learn More

Weekly Policy Update: Colorado Dept. of Labor Releases Final Rules on Equal Pay Transparency

In September, the Colorado Department of Labor and Employment (CDLE) published proposed rules on Equal Pay Transparency providing guidance for implementation of the state’s new Equal Pay for Equal Wor...

Learn More

Colorado Life Sciences Leaders Meet with Governor Jared Polis

Colorado BioScience Association (CBSA) brought leaders from Colorado’s life sciences community together to meet with Governor Polis, Lt. Governor Primavera, and their staff.  The group had the opportu...

Learn More

Weekly Policy Update: Key Takeaways from the Colorado Election

Colorado voters were highly motivated in this year’s election. In fact, the state experienced record turnout, with over 80% of eligible voters participating in the election. As predicted, Colorado con...

Learn More

Weekly Policy Update: Polis Releases FY 2021-22 Budget Request, Prioritizes Advanced Industries Accelerator Grant Program

Today Governor Polis submitted his budget request for the 2021 – 2022 fiscal year. The proposal calls for $35.4 billion in total funds and includes three key elements that the administration believes...

Learn More

CBSA and BIO Host Webinar: Developing + Distributing a COVID-19 Vaccine

CBSA partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the ecosystem’s work to develop and deliver a safe and effective COVID-19 vaccine. The discussion featured a...

Learn More

AΩA Honor Medical Society Funds Research + Education Fellowships for Future Medical Leaders

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: CBSA Virtual Roundtable with Congresswoman Diana DeGette

This week CBSA held a virtual roundtable with Congresswoman Diana DeGette, who represents Colorado’s first Congressional district. It was a great opportunity to showcase the critical health innovation...

Learn More

Weekly Policy Update: Polis Administration Holds Stakeholder Meeting on Canadian Drug Importation Program

On Thursday, the Department of Health Care Policy and Financing held a virtual stakeholder meeting to provide an update on the progress of Colorado’s Canadian drug importation program. The program was...

Learn More

CBSA Takes Positions on Statewide Ballot Measures Impacting Life Sciences Ecosystem

Colorado BioScience Association (CBSA) leads Policy + Advocacy for Colorado’s life sciences community. We work for a pro-innovation policy environment to accelerate the growth of our life sciences eco...

Learn More

Weekly Policy Update: Colorado Life Sciences Leaders Update Senator Bennet on Critical COVID-19 Innovations

This afternoon CBSA hosted a virtual roundtable with Senator Michael Bennet to provide updates on the innovative work underway in Colorado to defeat COVID-19. In his opening comments, the Senator talk...

Learn More

Amgen Foundation Support brings LabXchange Training to Colorado Teachers

Through the generous support of the Amgen Foundation, the Colorado BioScience Institute (Institute), in collaboration with the Harvard LabXchange creators, will begin training Colorado teachers on Lab...

Learn More

Weekly Policy Update: Colorado Dept. of Labor & Employment Issues Proposed Rules on Equal Pay Transparency

On September 29, the Colorado Department of Labor and Employment (CDLE) published proposed Equal Pay Transparency Rules (“EPT Rules”) providing guidance for implementation of the state’s new Equal Pay...

Learn More

Colorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum

For Immediate Release: October 1, 2020    Colorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum Two-Day Event Includes Unveiling of 2020-2021 BioScien...

Learn More

IMD Path Thinks Outside of the Box, Brings Strong Culture

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: FDA Moves Forward with Final Rule on Drug Importation

Yesterday the FDA issued their final rule and guidance on the importation of prescription drugs. They were first proposed last December, and CBSA worked with other state bioscience associations to sub...

Learn More

Weekly Policy Update: State Releases Updated Economic and Revenue Forecast

This morning, the Joint Budget Committee (JBC) heard presentations on the September economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB)....

Learn More

Weekly Policy Update: President Moves Forward with Most-Favored-Nation Drug Pricing Policy

On Sunday, President Trump issued an Executive Order on a drug pricing policy called “most-favored-nation.” The order directs the Secretary of Health and Human Services (HHS) to develop and implement...

Learn More

Colorado Partners with Google and Apple to Launch Contact Tracing App

At a press conference on Tuesday, Governor Jared Polis announced that Colorado will partner with Google and Apple on a contact tracing app for COVID-19. By the end of September, any resident with a sm...

Learn More

Weekly Policy Update: CMS Issues Proposed Rule to Improve Coverage for Breakthrough Technologies

This week the Centers for Medicare & Medicaid Services (CMS) released the long-awaited proposed rule on "Medicare Coverage of Innovative Technologies." The proposed rule would make significant cha...

Learn More

Weekly Policy Update: CBSA Member PharmaJet Hosts Visit with Senator Cory Gardner

CBSA member PharmaJet hosted a visit with U.S. Senator Cory Gardner this week to showcase their needle-free technology for vaccine and therapeutic delivery. It was a great opportunity for the company...

Learn More

CBSA - All Member Meeting 2020

CBSA brought our life sciences community together for our annual All-Member Meeting on August 19, led by CBSA Board Chair Bob Reddy of Medtronic and CBSA President and CEO Jennifer Jones Paton. Bob an...

Learn More

Weekly Policy Update: CBSA Engages Congressional Delegation to Protect Life Sciences Innovation

CBSA continues to engage the Colorado Congressional delegation around an executive order that the President announced on July 24 that would limit payment for Medicare Part B drugs to the lowest price...

Learn More

Weekly Policy Update: President Trump Issues ‘Buy American’ Executive Order

President Trump recently issued an executive order intended to increase federal support for the domestic manufacture of “essential medicines,” “medical countermeasures,” and “critical inputs” through...

Learn More

Weekly Policy Update: CBSA Advocates for Additional Relief for Life Sciences Startups + Growth Companies

CBSA supports H.R. 7917, the IGNITE American Innovation Act, bipartisan legislation recently introduced to ensure innovative and entrepreneurial companies can access the necessary liquidity to continu...

Learn More

Weekly Policy Update: CBSA Meets with Congressional Offices on the VALID Act

CBSA and our members met with Senator Michael Bennet and Rep. Diana DeGette’s offices this week to discuss the Verifying Accurate Leading-edge IVCT Development (VALID) Act, recent federal legislation...

Learn More

ClinImmune Labs Change Patient Outcomes in Unique Ecosystem

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: Energize Colorado Gap Fund Launches August 2020

The  Energize Colorado Gap Fund was created by Senate Bill 222 and will provide more than $25 million in small business loans and grants to boost small businesses impacted by COVID-19. Sole propr...

Learn More

Industry Experts Update State Policymakers on COVID-19 Efforts

Colorado BioScience Association is proud of how our life sciences ecosystem has responded to the outbreak of COVID-19. We have seen our members come together to address the crisis and commit resources...

Learn More

Weekly Policy Update: Federal Lawmakers Introduce Diagnostic Testing Bills

Recently, Colorado Representative Diana DeGette and Indiana Representative Larry Bucshon introduced two bills to increase diagnostic testing capabilities at public health laboratories, in hospitals, a...

Learn More

Weekly Policy Update: Read CBSA's 2020 Legislative Session Report

On June 15, the Second Regular Session of the 72nd General Assembly adjourned sine die, marking the end of a truly historic legislative session. During the first two months of the session, we saw the...

Learn More

Colorado BioScience PAC Educates State Candidates on Life Sciences Priorities

Last Tuesday was Colorado’s primary election, where voters decided on candidates for races including the U.S. Senate, U.S. House of Representatives, the state legislature, and other races like distric...

Learn More

ArtisanBio Cell Therapies Engineers Talent and Innovation

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Weekly Policy Update: New Small Business Loan and Grant Programs Signed into Law

On Tuesday, Governor Polis signed two state bills into law that will provide support for Colorado small businesses through low-interest loans and grants from the state. Both bills passed with bipartis...

Learn More

Weekly Policy Update: State Releases June Economic & Revenue Forecast

Today, the Joint Budget Committee (JBC) heard presentations on the June economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB). The takeaway...

Learn More

CBSA Advocates to Sustain a Supportive Tax Environment for Ecosystem

Just days before the end of the session, Colorado state legislators introduced House Bill 1420, a controversial measure that would eliminate critical tax breaks and relief for Colorado businesses of a...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close - Final Week Round Up

The legislative session continued for a third week with a wave of controversial bills, including the introduction of House Bill 1420, which would eliminate critical tax breaks and relief for Colorado...

Learn More

New Data Demonstrates Life Sciences Ecosystem Growth, Impact in Colorado

Numbers Signal Steady Jobs, Salary, and Funding Gains DENVER – Colorado BioScience Association shares newly released employment and federal funding data on life sciences in Colorado, demonstrating eco...

Learn More

CBSA Board Welcomes AGC Biologics

Colorado BioScience Association warmly welcomes AGC Biologics to our state. Last week, the global CDMO announced it will invest $100 million in a large-scale biopharmaceutical manufacturing facility i...

Learn More

Weekly Policy Update: Congress Passes New Law Creating More Flexibility in the Paycheck Protection Program

On Friday, President Trump signed into law the Paycheck Protection Program Flexibility Act. The new law addresses many concerns raised by the small business community about the Paycheck Protection Pro...

Learn More

CBSA Hosts Virtual Roundtable with Congressman Ed Perlmutter

This week, CBSA hosted a roundtable with Congressman Ed Perlmutter, who represents Colorado’s seventh Congressional district. It was a great opportunity for members of our community to ask questi...

Learn More

AGC Biologics Chooses Colorado, Invests $100 Million in Boulder Facility

On behalf of Colorado’s life sciences community, CBSA is pleased to welcome Global CDMO AGC Biologics to our state. The company invested $100 million in a 300,000-square-foot facility in Boulder and w...

Learn More

Congratulations, Advanced Industries Accelerator Grant Recipients

Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...

Learn More

AAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company

AveXis, a Novartis Company, agrees to contribute the use of its gene therapy manufacturing expertise to help produce and scale novel vaccine that uses adeno-associated virus (AAV) vector for clinical...

Learn More

Weekly Policy Update: State Legislature Resumes - Week One Round Up

On May 26, the Colorado state legislature resumed the 2020 session with a condensed list of bills. Here’s a quick recap of key bills that were heard this week. House Bill 1195, Consumer Digital Repair...

Learn More

Innovative Industries Internship Program Update

Since last fall, CBSA has been advocating for an extension of the Innovative Industries Internship Program, which is set to expire July 1 of this year. The program incentivizes employers to find, hire...

Learn More

CBSA + BIO Host Webinar on COVID-19 Innovation Pipeline

On May 21, Colorado BioScience Association (CBSA) partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the COVID-19 global development pipeline and how Colorado’s lif...

Learn More

DARTNet Pairs Technology and Research to Advance Medical Knowledge

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

Colorado BioScience Association Congratulates New Class of Boettcher Investigators

$1.88 million in biomedical research grant funding for 2020 Class DENVER, May 22, 2020 — The Boettcher Foundation has selected eight researchers to receive funding through the Boettcher Foundation’s W...

Learn More

In the Weeds: Joint Budget Committee + Advanced Industries Accelerator Grant Program

Since early May, the Joint Budget Committee (JBC) has been working to balance the state budget and review recommendations from the committee staff and the Governor’s Office of State Planning and Budge...

Learn More

Good News: Advanced Industries Accelerator Grant Program

We are excited to share good news about the Advanced Industries Accelerator Grant Program. Yesterday, the General Assembly’s Joint Budget Committee (JBC) decided to preserve the program and maintain a...

Learn More

Joint Budget Committee Delays Action Again on Advanced Industries Accelerator Grant Program

Last week, the Colorado General Assembly’s Joint Budget Committee (JBC) continued their work to balance the state budget and considered many of the remaining budget cut recommendations for each state...

Learn More

Weekly Policy Update: CBSA Provides Feedback on New Proposal for Antimicrobial Drug Development

Senator Michael Bennet is planning to introduce legislation that would create new incentives for the development of innovative antimicrobial drugs, called the Pioneering Antimicrobial Subscriptions to...

Learn More

CBSA Hosts Member Discussion with Congressman Jason Crow

On Wednesday, CBSA hosted a discussion with Congressman Jason Crow, who represents Colorado’s sixth Congressional district. The Congressman gave an update on his efforts to provide relief for small bu...

Learn More

Additional Support Needed: Advanced Industries Accelerator Grant Program

On Tuesday, the General Assembly’s Joint Budget Committee (JBC) delayed a vote on the Advanced Industries Accelerator Grant Program. The newest recommendation from budget committee staff would elimina...

Learn More

Weekly Policy Update: CBSA Fights to Protect the Advanced Industries Accelerator Grant Program

Earlier this week, staff analysts for the Joint Budget Committee (JBC) presented revised figure setting documents to guide the JBC as they work to balance the budget over the coming weeks. The documen...

Learn More

Your Support Needed Now – Advanced Industries Accelerator Grant Program

Colorado is facing massive budget shortfalls due to the COVID-19 pandemic. This puts the flagship funding program for life sciences in Colorado at risk. The Advanced Industries Accelerator Grant Progr...

Learn More

Meet Avidity, The "Connection" Company

Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!

Learn More

CBSA Hosts Virtual Town Hall with Senator Cory Gardner

On Monday, CBSA hosted a virtual town hall with Senator Cory Gardner. More than 65 members and leaders of Colorado’s life sciences community came together to ask questions and offer feedback about the...

Learn More

Weekly Policy Update: Governor Polis Issues Safer at Home Executive Order

On Sunday, Governor Polis issued a new Executive Order to move Colorado to the Safer at Home phase. The Safer at Home Order phases in the reopening of certain businesses over the next week, while cont...

Learn More

What the New Federal Relief Package Means for Life Sciences

On April 23, the U.S. House of Representatives passed the Paycheck Protection Program and Health Care Enhancement Act, and the following day President Trump signed the bill into law. The $484 billion...

Learn More

Colorado BioScience Association Appoints Executives from Medtronic, Amgen to Lead Board of Directors

Bob Reddy of Medtronic Enabling Technologies, Dr. Kiki Traylor of Amgen Named Board Chair and Vice Chair Denver – Colorado BioScience Association (CBSA) today welcomed new officers and members to...

Learn More

Weekly Policy Update: As Congress Considers Next Phase of Relief, CBSA Invites Members to Weigh In

Just days after President Trump signed the CARES Act into law, Members of Congress were already talking about the need for a fourth relief package to help ease the economic pain created by the pandemi...

Learn More

Weekly Policy Update: Colorado General Assembly Sets Tentative Date to Resume Session

The Colorado General Assembly’s top-ranking lawmakers from each party met on Wednesday to discuss a number of big issues they’re facing. First, legislative leadership determined that the General Assem...

Learn More

Senator Bennet, FDA Updated on Colorado COVID-19 Innovations

CBSA continues to work with federal, state and local officials to advocate for our life sciences ecosystem and facilitate connections for companies and organizations working on COVID-19. On Monday, we...

Learn More

Beginning Today – New Loans Available for Small Businesses Under CARES Act

There’s immediate relief for small businesses affected by COVID-19 under the CARES Act. New loans are available through the Paycheck Protection Program beginning today, Friday, April 3, for small comp...

Learn More

CARES Act Stimulus Package: What it Means for Life Sciences in Colorado

This afternoon, President Trump signed into law S. 3548, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The $2 trillion relief package is the largest economic stimulus measure in mode...

Learn More

Life Sciences + Statewide Stay-at-Home Order

Colorado is now under a Stay-at-Home-Order issued by Governor Jared Polis. The order requires everyone in Colorado to stay in their place of residence, except for certain necessary activities, essenti...

Learn More

Life Sciences and Stay-at-Home Orders

The City and County of Denver and the City of Boulder issued stay-at-home orders on Monday following the Governor’s directive on in-person workforce reduction during the COVID-19 pandemic. CBSA antici...

Learn More

Urgent – Open Positions with the State and Children’s Hospital

Colorado BioScience Association is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s team is aski...

Learn More

COVID-19: Life Sciences and the Governor’s In-Person Workforce Reduction Order

On Sunday, Governor Polis issued an Executive Order that requires all non-critical businesses in the state to reduce their in-person workforce by 50% due to the COVID-19 pandemic. It requires all non-...

Learn More

Weekly Policy Update: CBSA Supports Life Sciences Ecosystem in the Fight Against COVID-19

During these challenging times, CBSA is focused on supporting our ecosystem and its response to the COVID-19 pandemic. We continue to engage with our local, state, and federal elected officials to ens...

Learn More

Weekly Policy Update: Colorado State Legislature Suspends Session for Two Weeks

To do their part in slowing the spread of COVID-19, the Colorado General Assembly met on Saturday, March 14th and passed a Joint Resolution to temporarily adjourn until March 30. The legislature also...

Learn More

CBSA on COVID-19

Businesses and organizations here in Colorado and around the world are all managing through the impact of COVID-19 on their business operations and personal lives. Our ecosystem’s work to drive health...

Learn More

COVID-19: CBSA Business Resource Guide

Last updated: April 6, 2020 Urgent: CBSA is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s tea...

Learn More

Weekly Policy Update: State Legislators Introduce Bill to Extend Innovative Industries Internship Program

State legislators introduced a bill this week to extend the Innovative Industries Internship Program for another five years. The program was created in 2015 to meet the critical needs of Colorado’s lo...

Learn More

Colorado BioScience Association Offers FDA Leader’s Perspective During Keynote at Medical Device Symposium

Dr. Jeffrey Shuren to Join Conference Live via Video from Washington, D.C. DENVER – Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medi...

Learn More

Weekly Policy Update: CBSA Meets with Federal Policymakers to Discuss Coverage + Payment for Breakthrough Technologies

CBSA was in DC this week representing Colorado’s life sciences ecosystem as part of the AdvaMed Fly-in. It was a great opportunity to meet with the Colorado delegation offices and advocate for federal...

Learn More

Weekly Policy Update: Health Care Stakeholders Convene to Discuss Total Cost of Care Legislation

At a stakeholder meeting on Tuesday the Colorado Hospital Association walked through their draft proposal for a total cost of care model in Colorado. Based on programs already operating in Oregon and...

Learn More

Weekly Policy Update: Drug Price Transparency and Drug Importation Bills Pass Health Committees

CBSA was at the Colorado State Capitol again this week to voice our concerns about legislation focused on drug price transparency and prescription drug importation. House Bill 1160, Drug Price Transpa...

Learn More

Weekly Policy Update: CBSA Represents Colorado’s Life Sciences Ecosystem in Senate Committee Hearings

This week, CBSA weighed in on Senate Bill 10, Repeal Ban on Local Government Regulation of Plastics, to ensure life-saving medicines and medical devices are not impacted by local regulations on single...

Learn More

Denver Business Journal Covers New Partnership to Fund Early-Stage Life Sciences Companies

Colorado BioScience Association and Rockies Venture Club recently announced a new effort to fund early-stage life sciences companies in Colorado, funded by an Advanced Industries Accelerator Grant fro...

Learn More

Colorado BioScience Association Highlights Life Sciences Impact at the State Capitol OEDIT Executive Director Betsy Markey Keynotes CBSA’s Annual Day at the Capitol

DENVER – Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations to the State Capitol today, February 4, 2020, to share innovation stories with le...

Learn More

Weekly Policy Update: CBSA Opposes Expanded Prescription Drug Importation Program

Last week Senator Joann Ginal introduced Senate Bill 119, Expand Canadian Prescription Drug Import Program. The bill builds on legislation that was enacted last session, that directed the Dept. of Hea...

Learn More

Weekly Policy Update: Drug Price Transparency Bills Introduced in the House and Senate

Over the past week, state legislators have introduced two drug price transparency bills that could impact our life sciences community. The first bill (SB20-107) was introduced in the Senate by Sen. Jo...

Learn More

New Investments Boost Colorado's Life Sciences Community

FOR IMMEDIATE RELEASE Rockies Venture Club and Colorado BioScience Association partner to fund Colorado Life Sciences startups in a new program backed by OEDIT Denver, CO - The Rockies Venture Club an...

Learn More

Weekly Policy Update: New Legislation Impacting Colorado’s Life Sciences Ecosystem

The CBSA team is hard at work advocating on behalf of Colorado’s life sciences ecosystem. After the first full week of the legislative session, here’s an update on where we’re engaging and why. CBSA L...

Learn More

CBSA CEO Honored by the Denver Business Journal

Congratulations to CBSA President and CEO Jennifer Jones Paton! The Denver Business Journal named Jennifer to its prestigious 40 Under 40 list, released this week. The DBJ names a class of 40 Under 40...

Learn More

Weekly Policy Update: Colorado Policymakers Outline Top Priorities for 2020 Session

Colorado lawmakers returned to the Capitol on Wednesday for the start of the 2020 legislative session, where both parties laid out their top priorities. After calling for civility and bipartisanship,...

Learn More

Weekly Policy Update: CBSA’s Priorities for the 2020 Legislative Session

January 8th marks the first day of Colorado’s 2020 legislative session, but CBSA has already been hard at work advocating on behalf of our members and the patients they serve. This session, we will co...

Learn More

Congress Votes to Repeal Medical Device Excise Tax

This week Congress voted to pass a full and permanent repeal of the medical device excise tax as part of legislation to fund the federal government through the rest of the current fiscal year. This is...

Learn More

Colorado Life Sciences Companies Raise $750 Million in 2019 Pfizer Acquisition of Array BioPharma Brings Ecosystem Total to $12.1 Billion

DENVER – Colorado’s life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of Boul...

Learn More

Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation 

Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation  On Monday, CBSA sent a comment letter to Rep. Dominique Jackson and Rep. Dylan Roberts outlining our comment...

Learn More

Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program

Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program  Earlier this year, CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility, and Sharklet...

Learn More

Colorado BioScience Association Recognizes Denver Partners for Bold Brand and New Website

Brand update delivers results for CBSA and Colorado’s life sciences ecosystem Denver – Colorado BioScience Association (CBSA) recognizes two Denver-area firms, Primavera Group and Watermark, for gener...

Learn More

Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award

Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award CBSA was proud to present Senator Cory Gardner with the American Life Sciences Innovation Counci...

Learn More

Policy Update: CBSA and Health Scholars Host State Rep. Shannon Bird

Learn More

CBSA Annual Awards Dinner Celebrates the Life of Adam Rubenstein

CBSA celebrated the life of Adam Rubenstein at the 16th Annual Awards Dinner.

Learn More

Policy Update: Colorado Votes

Policy Update: Colorado Votes Colorado voters decided on two major ballot measures on Election Day 2019. Proposition DD asked voters to legalize sports betting in Colorado and create a 10 percent tax...

Learn More

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner Biodesix Named Company of the Year, Securisyn Medical Honored as Rising Star Denver,...

Learn More

Policy Update: Governor Jared Polis Releases Budget Proposal for FY 2020-21

Governor Jared Polis Releases Budget Proposal for FY 2020-21 Governor Jared Polis released his 2020-21 budget proposal on Friday, underscoring priorities that include expanding the state’s preschool p...

Learn More

Colorado BioScience Association Reveals New Website, Bold Brand

For Immediate Release: October 31, 2019 Colorado BioScience Association Reveals New Website, Bold Brand    Highlights Co-Opportunity, Colorado’s Collaborative, Pro-Innovation Environmen...

Learn More

CBSA Co-opportunity Means…

Health innovations from Colorado make a global impact.

Learn More

Weekly Policy Update: CBSA Co-Hosts Aurora Facility Tour for State Senator Rhonda Fields

This week CBSA partnered with CSL Behring to host state Senator Rhonda Fields for a tour of the CSL Plasma Collection Center in Aurora. On the tour, the collection center managers were able to show Se...

Learn More

Colorado BioScience Association Welcomes New Appointees to the Board of Directors

Colorado BioScience Association Welcomes New Appointees to the Board of Directors For Immediate Release: October 25, 2019 Colorado BioScience Association Welcomes New Appointees to the Board of Direct...

Learn More

Weekly Policy Update: CBSA Partners with LivaNova to host Rep. Brianna Titone

This week CBSA partnered with LivaNova to host state Rep. Brianna Titone for a tour and employee town hall at the company’s Arvada facility. It was a great opportunity to showcase the devices that are...

Learn More

Weekly Policy Update: State Releases Draft Proposal for Public Health Insurance Option

  On Monday, the Colorado Division of Insurance and the Department of Health Care Policy and Financing released a draft report on the development of the state’s plan for a public health insurance...

Learn More

Weekly Policy Update: CBSA Urges Congress to Reject Proposals that Adopt Foreign Price Controls

CBSA is committed to ensuring patients have access to the treatments they need. We appreciate the bipartisan efforts underway by the Trump Administration and Congress to provide patients relief from h...

Learn More

Weekly Policy Update: House Speaker Nancy Pelosi Releases Proposal on Prescription Drug Pricing

On September 19, House Speaker Nancy Pelosi released a long-anticipated proposal intended to reduce prescription drug prices. H.R. 3, the Lower Drug Costs Now Act of 2019, includes the following provi...

Learn More

Weekly Policy Update: Zimmer Biomet Spine Hosts Congressman Ed Perlmutter at Westminster Facility

At the end of August, Congressman Ed Perlmutter (CO-07) visited Zimmer Biomet Spine in Westminster to tour the medical education training facilities, biomechanics labs, and manufacturing area. Followi...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: CBSA Hosts Congressman Jason Crow (CO-06)

  This month CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility and Sharklet Technologies to host Congressman Jason Crow (CO-06) for a campus tour and roundtable...

Learn More

Weekly Policy Update: CBSA Meets with Executive Director of OEDIT

  This week CBSA President & CEO Jennifer Jones Paton and Vice President Emily Roberts met with Betsy Markey, Executive Director of the Office of Economic Development and International Trade...

Learn More

Weekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax

Last week we asked the Colorado bioscience community to take action and urge our Members of Congress to support permanent repeal of the medical device excise tax. The tax is a threat to medical innova...

Learn More

Weekly Policy Update: End the Device Tax

The Colorado BioScience Association strongly opposes the medical device tax, a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act. Since its...

Learn More

Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

This week the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) released a plan that describes the steps they will take to allow importation of certain drugs fro...

Learn More

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access

This week CBSA vice president Emily Roberts joined other state advocates in Washington, DC for the We Work For Health Summit. During the two-day event, advocates met with their respective delegation t...

Learn More

Viewray to Expand to Denver, Adding 274 Jobs

Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...

Learn More

Weekly Policy Update: Trump Administration Pulls Rebate Rule

Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...

Learn More

Weekly Policy Update: Drug Pricing Bills Pass Key Senate Committees

Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....

Learn More

Weekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap

The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...

Learn More

New State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...

Learn More

Pfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion

Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...

Learn More

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals

WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...

Learn More

Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...

Learn More

Colorado BioScience Association Celebrates State’s Collaborative Nature

New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals DENVER – Colorado BioScience Association (CBSA) today launched the new issue of its annual magazine, BioSc...

Learn More

Improving the Reimbursement Landscape for Medical Technology Innovators

CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s...

Learn More

27 Companies Share 6.1 Million Dollars in 2019 Advanced Industries Accelerator Grants

Colorado BioScience Association congratulates the 27 companies recently recognized as valuable investments for the entire state by the Office of Economic Development and International Trade’s (OEDIT)...

Learn More

CMS Rolls Back Harmful Proposals in Medicare Part D

Last Thursday CMS finalized a rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, which included a number of significant changes to the proposed r...

Learn More

Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...

Learn More

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...

Learn More

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...

Learn More

CBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs

Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...

Learn More

Weekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax

This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical I...

Learn More

Weekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC

This week CBSA testified in the House Health and Insurance Committee in opposition to House Bill 1296 – Prescription Drug Cost Reduction Measures. The bill requires health insurers, prescription drug...

Learn More

CBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology

Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization...

Learn More

Weekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy

This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Thro...

Learn More

Weekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation

Last week the non-partisan Legislative Council published the forecast for the economy and state government revenue through FY 2019-20. The forecast showed that while the economy will continue to grow...

Learn More

Weekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget

On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run fami...

Learn More

Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

This week CBSA held our annual Day at the Capitol event, bringing healthcare innovators to the state Capitol to highlight the discoveries and advancements taking place in Colorado to improve the healt...

Learn More

Colorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium

Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy DENVER – Colorado BioScience Association (CBSA) focuses on the opportunities offered by blockchain...

Learn More

Weekly Policy Update: AdvaMed Fly-In and the Monthly Report

This month CBSA Vice President Emily Roberts met with Members of the Colorado Congressional delegation as part of the AdvaMed State Medical Technology Alliance (SMTA) Fly-In. This event brings togethe...

Learn More

Weekly Policy Update: CBSA and LivaNova Partner to Host Senator Cory Gardner

This week CBSA partnered with LivaNova to host Senator Cory Gardner at LivaNova’s Arvada facility. The event included a brief meeting with the Senator and his staff, followed by a tour of the facility...

Learn More

Colorado BioScience Association connects lawmakers to patient-focused innovators at Capitol event

New results highlight success of state-funded grant program for early-stage life science companies DENVER – Colorado BioScience Association (CBSA) brings healthcare innovators to the state Capitol to...

Learn More

Weekly Policy Update: CBSA Opposes House Bill 1131, Prescription Drug Cost Education

This week, CBSA attended a stakeholder meeting on House Bill 1131, Prescription Drug Cost Education. As the bill is currently written; it requires a drug manufacturer, wholesaler, agent or an employee...

Learn More

Weekly Policy Update: Trump Administration Takes Step to Encourage Direct Discounts to Patients

On Tuesday President Trump gave his State of the Union address, in which he described the need to rein in health care costs as a major priority. The President also laid out an ambitious health care ag...

Learn More

Colorado BioScience Association Appoints Emily Roberts as New Vice President

Roberts to Oversee Policy and Communications at Life Science Organization DENVER – Colorado BioScience Association (CBSA) announces the appointment of Emily Roberts to vice president. Roberts takes ov...

Learn More

Weekly Policy Update: Prescription Drug Importation and CBSA’s Day at the Capitol

Yesterday the Colorado BioScience Association testified in opposition to Senate Bill 005, which tasks the department of health care policy and financing to design a program to import prescription phar...

Learn More

Weekly Policy Update: Colorado Bioscience Championed in Denver Business Journal

Colorado BioScience Association is focused on increasing our companies’ access to capital and highlighting the innovative work coming out of our state. Our team recently collaborated with the Denver B...

Learn More

Weekly Policy Update: Importing Drugs and the Governor's Budget

Last week CBSA took an opposition position to Senate Bill 005 – Import Prescription Drugs from Canada. As a reminder this bill would create the "Colorado Wholesale Importation of Prescription Drugs Ac...

Learn More

Weekly Policy Update: New General Assembly, Inauguration, and Bill Introductions

This marks the first full week of the 72nd First Regular Session of the Colorado General Assembly. It was a busy week with bill introductions, Governor Polis’ Inauguration and the State of the State (...

Learn More

Weekly Policy Update: CBSA’s Policy Priorities for 2019

Today, January 4, 2019 marks the first of 120 days of the 72nd General Assembly. CBSA looks forward to advocating on behalf of our members, industry and the patients we serve. We also look forward to...

Learn More

Colorado Bioscience Companies Raised $1 Billion in 2018

International Investors Contributed to the State’s Largest Financings DENVER – Colorado’s life science sector raised $1 billion in 2018, entering a second year of fundraising exceeding the $1 billion...

Learn More

Weekly Policy Update: More Medical Device Tax News and the 2018 Farm Bill

TheHouse Ways and Means Committee this week released a new extenders package which included a 5-year extension on the medical device excise tax moratorium. The 2.3% levy on the sale of prescribed medi...

Learn More

Weekly Policy Update: Protecting Medicare Beneficiaries and Medical Device Tax Work

A recent proposal by the Centers for Medicare & Medicaid Services (CMS) would implement an unprecedented Part B demo that could harm Medicare beneficiaries. We believe this would alter the entire...

Learn More

Weekly Policy Update: November Recap

The November Focus newsletter was published this afternoon with Jennifer’s recap of the full month in policy news. Topics covered include: November Elections At the federal level Republicans have reta...

Learn More